StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JPMorgan Downgrades Tempus AI Inc (TEM) to Neutral
February 25, 2025 5:13 AM
JPMorgan analyst Rachel Vatnsdal downgraded Tempus AI Inc (NASDAQ: TEM) from Overweight to Neutral with a price target of $55.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Downgrades
Next Articles
Stifel Reiterates Hold Rating on Tempus AI Inc (TEM)
February 25, 2025 9:09 AM
Form S-8 Tempus AI, Inc.
February 24, 2025 4:53 PM
After-hours movers: Zoom, Hims & Hers Health, Tempus AI, and more
February 24, 2025 4:50 PM
Form 10-K Tempus AI, Inc. For: Dec 31
February 24, 2025 4:06 PM
Tempus AI, Inc (TEM) Reports Q4 Loss of $0.18
February 24, 2025 4:04 PM
Form 8-K Tempus AI, Inc. For: Feb 24
February 24, 2025 4:02 PM
Tempus Reports Fourth Quarter and Full Year 2024 Results
February 24, 2025 4:01 PM
Tempus AI (TEM) call put ratio 1.6 calls to 1 put into quarter results and outlook
February 24, 2025 10:46 AM
Tempus AI (TEM) call put ratio 1.4 calls to 1 put into quarter results
February 24, 2025 5:01 AM
Tempus AI (TEM) call put ratio 2.3 calls to 1 put into quarter results
February 21, 2025 11:00 AM
Tempus AI (TEM) and Stemline Therapeutics Collaborate to Implement Tempus Next
February 21, 2025 8:33 AM
Tempus and Stemline Therapeutics, Inc., A Subsidiary of the Menarini Group, Announce Collaboration to Implement Tempus Next, an AI-Enabled Care Pathway Intelligence Platform to Support Patients with M
February 21, 2025 8:30 AM
Tempus AI (TEM) call put ratio 1.9 calls to 1 put into quarter results
February 21, 2025 6:21 AM
